Group II phospholipase A2 in nasal fluid, mucosa and paranasal sinuses

Acta Oto-Laryngologica

Volumn 117, Issue 6, 1997, Pages 860-863

  Aho, Heikki J ^a   Grénman, Reidar ^a   Sipilä, Jukka ^a   Peuravuori, Heikki ^a   Hartikainen, Jouko ^a   Nevalainen, Timo J ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Anti infective agents; Lysozyme; Nose

Indexed keywords

LYSOZYME; PHOSPHOLIPASE A2;

ANTIBACTERIAL ACTIVITY; ANTIBODY SPECIFICITY; ARTICLE; ENZYME RELEASE; HUMAN; HUMAN CELL; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; LACRIMAL DUCT; NOSE MUCOSA; NOSE MUCUS; NOSE SECRETION; PARANASAL SINUS; PRIORITY JOURNAL; PROTEIN SECRETION; SYNOVIAL FLUID;

EID: 0030718977     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489709114215     Document Type: Article

References (24)

1. van den Bosch H. Intracellular phospholipases A. Biochim Biophys Acta 1980; 604: 191-246.
2. 2+-dependent translocation domain with homology to PKC and GAP. Cell 1991; 65: 1043-51.
3. 2. J Biol Chem 1989; 264: 5768-75.
4. 2 present in rheumatoid arthritic synovial fluid. J Biol Chem 1989; 264: 5335-8.
5. 2. Biochem Soc Trans 1990; 18: 781-5.
6. 2 human tissues. Inflammation 1993; 17: 453-64.
7. 2 in inflammatory diseases. Clin Chem 1993; 39: 2453-9.
8. 2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991; 266: 2647-51.
9. 2 in hepatocytes in a patient with epitheloid hemangioendothelioma of the liver. Lab Invest 1996; 74: 585-91.
10. 2. J Clin Invest 1995; 95: 603-10.
11. 2. J Clin Invest 1996; 97: 250-7.
12. Fleming A. On a remarkable bacteriolytic element found in tissues and secretions. Proc R Soc Biol (London) 1922; 93: 306-17.
13. Franken C, Meijer CJLM, Dijkman JH. Tissue distribution of antileukoprotease and lysozyme in humans, J Histochem Cytochem 1989; 37: 493-8.
14. Ishida M, Matsunaga T, Uda H. An immunohistological study of nasal and paranasal mucosa of patients with relapsing chronic sinusitis. Rhinology 1984; 22: 115-8.
15. 2 and lysozyme in lacrimal glands. Invest Ophthalmol Vis Sci 1996; 37: 1826-32.
16. 2 by lacrimal gland. Invest Ophthalmol Vis Sci 1994; 32: 417-21.
17. Stadel JM, Hoyle K, Naclerio RM, Roshak A, Chilton FH. Characterization of phospholipase An from human nasal lavage. Am J Respir Cell Mol Biol 1994; 11: 108-13.
18. 2 into nasal fluids after allergenic challenge: Possible role in the regulation of platelet activating factor release. J Allergy Clin Immunol 1994; 94: 109-19.
19. Andersson M, Greiff L, Svensson C, Persson C. Various methods for testing nasal responses in vivo: a critical review. Acta Otolaryngol (Stockh) 1995; 115: 705-13.
20. 2 in human serum. Clin Chem 1992; 38: 1824-9.
21. Hsu SM, Raine L, Fanger H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-80.
22. 2 in cartilage. J Rheumatol 1993; 20: 325-30.
23. Vigneswaran N, Wilk CM, Heese A, Hornstein OP, Naumann GOH. Immunohistochemical characterization of epithelial cells in human lacrimal glands. I. Normal major and accessory lacrimal glands. Graefe's Arch Clin Exp Ophthalmol 1990; 228: 58-64.
24. Records RE. The tear film. In: Tasman W, Jaeger EA, eds. Duane's Foundations in Clinical Ophthalmology. Vol. 2. Chapter 3. Philadelphia: J.B. Lippincott, 1991: 1-22.